Issues
The House Childhood Cancer Caucus supports bipartisan efforts to reauthorize and strengthen the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA).
Children’s Hospitals Graduate Medical Education (CHGME) Funding
The Childhood Cancer Caucus strongly supports the Children’s Hospital Graduate Medical Education (CHGME) program which provides freestanding children’s hospitals with federal GME funding to support pediatric medical training and research. Over the past decade, CHGME has successfully expanded and improved the delivery of pediatric health care across the nation.
Every day in the United States 36 children are diagnosed with cancer. A total of 2,500 children will die from these diseases each year. Pediatric cancer is the leading cause of disease-related death for children in the United States. Greater support is needed to research the causes and potential treatments for this deadly disease. This was the purpose of the Caroline Pryce Walker Conquer Childhood Cancer Act, which was signed into law in 2008.
‘Creating Hope Act’ Has Broad Bipartisan Support
WASHINGTON, D.C.— Congressmen Michael McCaul (R-TX), G.K. Butterfield (D-NC), Sue Myrick (R-NC), and Chris Van Hollen (D-MD) introduced legislation that would incentivize pharmaceutical companies to develop new drugs for rare pediatric diseases, such as childhood cancers, that have not been developed in decades because they are not profitable. Senators Bob Casey (D-PA) and Scott Brown (R-MA) introduced a companion bill, S. 606.
Addressing the Psychosocial Needs of Children with Cancer
Rep. Chris Van Hollen (D-MD) and Rep. Michael McCaul (R-TX) introduced H.Res. 262, Supporting efforts to raise awareness, improve education, and encourage research and treatment of the psychosocial needs of children diagnosed with a childhood cancer.
Speier-McCaul Introduce Legislation to Improve Treatment of Childhood Cancer Survivors
WASHINGTON, DC- Congresswoman Jackie Speier (D-CA) and Congressman Michael McCaul (R-TX) introduce bipartisan legislation to improve and advance the treatment of childhood cancer survivors.